Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion

Citation
C. Curdy et al., Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion, J CONTR REL, 76(1-2), 2001, pp. 73-79
Citations number
19
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF CONTROLLED RELEASE
ISSN journal
01683659 → ACNP
Volume
76
Issue
1-2
Year of publication
2001
Pages
73 - 79
Database
ISI
SICI code
0168-3659(20010911)76:1-2<73:PDIHSC>2.0.ZU;2-5
Abstract
A nonsteroidal anti-inflammatory drug, piroxicam, was administered from a c ommercially available gel to human volunteers both passively and under the application of an iontophoretic current. The effect of occlusion on the pas sive delivery of piroxicam was also examined in a separate series of experi ments. After treatment, the stratum corneum (SC) at the site of application was progressively tape-stripped and piroxicam transport into the membrane was assessed by UV analysis of drug extracted from the tape-strips. Analysi s of variance did not show any significant difference between passive pirox icam delivery after 30, 60 or 125 nun. However, current application enhance d drug uptake into the SC, as indicated by both increased piroxicam concent rations in the horny layer and detectable concentrations at greater depths into the membrane. The total amount of drug recovered in the SC post-iontop horesis was significantly higher than that found following passive diffusio n for each application time. The amounts of drug recovered from the tapes a fter 60 and 125 min of current application were significantly higher than t hat after 30 min treatment. Finally, the in vivo SC concentration profiles following passive delivery were fitted to the appropriate solution of Fick' s second law of diffusion to determine skin partitioning and diffusivity pa rameters. (C) 2001 Elsevier Science B.V. All rights reserved.